VICTOR2™ D System
The VICTOR2™ D platform has been used in over 200 NBS laboratories all over the world. The large number of users is a testament to the quality and reliability of the platform: nearly 10 million newborns are screened with with the VICTOR2™ D platform each year. The semi-automated system is a robust, cost-efficient solution for screening of seven NBS disorders: congenital hypothyroidism, phenylketonuria, congenital adrenal hyperplasia, galactosemia, cystic fibrosis, biotinidase deficiency and G6PD deficiency.